Valink Therapeutics
Discovering bispecific antibody drug-conjugates (BsADC) against cancer
Boston , US
Biotech
Therapeutics
Drug discovery
Valink Therapeutics develops next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by incorporating multiple antibody modifications at once, rapidly and scalable generating complex drug candidates (bi-/multispecificity, multivalency and drug-conjugation in a single discovery process). Our research focus is on solid tumours poorly addressed by immunotherapy.
- Projects
- Team
- Jobs
- News
No projects yet.
This company hasn't published any projects. Be the first to launch one!
Create Your First ProjectFounded2021
Team Size15
LocationUS
Websitewww.valinktx.com/
🏳️
Claim This ListingIs this your company?
Claim this listing to manage your profile, add updates, and connect with your audience.